Oncolinx
Company

Last deal

$1M

Amount

Seed

Stage

27.10.2016

Date

3

all rounds

$1.06M

Total amount

date founded

Financing round

General

About Company
Oncolinx is developing antibody-drug conjugates that target cancer cells without harming healthy cells.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2013

Number of employees

Company Type

For Profit

Last funding type

Seed

IPO status

Private

Description

The company's patented Azonafide drug payload is carried exclusively to cancer cells through the use of ADCs, which are being developed in partnership with over 14 leading pharmaceutical companies and 6 academic labs worldwide. These ADCs are being developed for use in 30 different cancer indications and have the potential to revolutionize cancer treatment by reducing the adverse side effects associated with traditional chemotherapy. Oncolinx aims to enter clinical trials with a partnered program in mid-2017 and is well-positioned to become a leader in the development of targeted cancer therapies.
Contacts

Contact Email

Phone number

Social url

Similar Companies
1000
Catapult Therapeutics

Catapult Therapeutics

Catapult Therapeutics is a Dutch biotech company developing an innovative anti-CCR7 antibody for cancer treatment.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Medical

Location

Lelystad, Netherlands
Lyell Immunopharma

Lyell Immunopharma

Lyell Immunopharma is developing cellular therapies to cure cancer.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Software, Health Care

Location

South San Francisco, CA, USA

total rounds

2

total raised

$493M

count Of Investments

6
Advanced Proteome Therapeutics

Advanced Proteome Therapeutics

Advanced Proteome Therapeutics is a biotech company that develops novel therapeutics for cancer treatment.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Therapeutics

Location

Boston, MA, USA

total rounds

8

total raised

$3.89M
HiberCell

HiberCell

HiberCell is a biotech company developing cancer treatments.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

New York, NY, USA

total rounds

3

total raised

$158.15M

Financials

Funding Rounds
3
3

Number of Funding Rounds

$1.06M

Money Raised

Their latest funding was raised on 27.10.2016. Their latest investor 43North. Their latest round Seed

Date 
Funding Round 
Investors 
Money Raised 
Lead 
27.10.2016
1
$1M
01.05.2016
1
$57.28K
Local Amount - EUR 50K
29.10.2014
1
43North

43North

43North is an accelerator program that invests $5 million per year to attract and retain high-growth startups in Buffalo, NY.

Sector

General Industrials

Subsector

Diversified Industrials

Keywords

Venture Capital, Financial Services

Location

Buffalo, NY, USA

count Of Investments

68

count Of Exists

6
Co-Investors
Investors
3
1

Number of lead investors

3

Number of investors

Investor 
Lead 
Round 
Partners 
Yes
Seed
No
Non-equity Assistance
43North

43North

43North is an accelerator program that invests $5 million per year to attract and retain high-growth startups in Buffalo, NY.

Sector

General Industrials

Subsector

Diversified Industrials

Keywords

Venture Capital, Financial Services

Location

Buffalo, NY, USA

count Of Investments

68

count Of Exists

6
EASME - EU Executive Agency for SMEs

EASME - EU Executive Agency for SMEs

EASME manages EU programs for SMEs, environment, energy, and maritime projects.

Sector

Industrial Support Services

Subsector

Professional Business Support Services

Keywords

Energy, Project Management

Location

Brussels, Belgium

count Of Investments

3607

count Of Exists

165
MassChallenge

MassChallenge

MassChallenge is a global accelerator that supports startups without taking equity.

Sector

Health Care Providers

Subsector

Health Care Services

Keywords

Financial Services

Location

Boston, MA, USA

total rounds

1

total raised

$50K

count Of Investments

3143

count Of Exists

173

People

Founders
4
Navin Nathan
Navin Nathan

Navin Nathan

Navin Nathan is the Co-Founder and COO at LMNT Accessories LLC. He attended the D'Amore-McKim School of Business at Northeastern University.

current job

LMNT Accessories
LMNT Accessories

organization founded

2

Navin Nathan

Sourav Sinha
Sourav Sinha

Sourav Sinha

Sourav Sinha is the Founder and CEO of Oncolinx LLC. Oncolinx is an early-stage bio-oncology company focused on creating targeted cancer therapies carry drugs directly to cancer cells and not healthy cells--avoiding many of the adverse side-effects of cancer. Oncolinx is partnered with more than 15 leading pharmaceutical partners, and 6 academic labs all over the world. Sourav also serves as the Entrepreneur In Residence of The Center For Advancing Innovation (CAI), a first-of-its-kind initiative to spin out the best inventions from the NIH, NCI, NASA, and other government funded agencies. Most uniquely, the fund redirects much of the value created into regional endowments to create jobs, increase prosperity, and support future sustainability. Sourav was named as a top 50 global entrepreneur under the age of 25 by Inc. Magazine and has been published in top scientific journals. Sourav holds an AB from Dartmouth College in Molecular Biology and Biochemistry, an MA in Biomedical Sciences from Rutgers Biomedical Health Sciences, and is a graduate of the Singularity University Global Solutions Program.

current job

Longevity Vision Fund
Longevity Vision Fund

organization founded

1

Sourav Sinha

Riley Ennis
Riley Ennis

Riley Ennis

Riley is a Thiel Fellow who created a cancer vaccine with his previous company Immudicon as Co-Founder & Chair. Co-Founder, COO at Freenome.

current job

Oncolinx
Oncolinx

organization founded

2

Riley Ennis

Allen Lin
Allen Lin

Allen Lin

current job

Oncolinx
Oncolinx

organization founded

1

Allen Lin

Employee Profiles
4
Riley Ennis

Riley Ennis

Co-Founder

Sourav Sinha

Sourav Sinha

Co-founder, CEO

Allen Lin

Allen Lin

Co-Founder and CSO

Activity

Recent News
0